Chemoinformaics analysis of 4-Methoxymethoxy-4-methyl-hex-2-ynal
| Molecular Weight | 170.208 | nRot | 4 |
| Heavy Atom Molecular Weight | 156.096 | nRig | 2 |
| Exact Molecular Weight | 170.094 | nRing | 0 |
| Solubility: LogS | -0.97 | nHRing | 0 |
| Solubility: LogP | 1.218 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 26.7711 |
| nHD | 0 | BPOL | 18.3849 |
| QED | 0.358 |
| Synth | 4.092 |
| Natural Product Likeliness | 0.731 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.134 |
| MDCK | 0.0000413 |
| BBB | 0.988 |
| PPB | 0.782313 |
| VDSS | 1.14 |
| FU | 0.0880521 |
| CYP1A2-inh | 0.153 |
| CYP1A2-sub | 0.942 |
| CYP2c19-inh | 0.423 |
| CYP2c19-sub | 0.877 |
| CYP2c9-inh | 0.251 |
| CYP2c9-sub | 0.111 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.399 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.458 |
| CL | 7.806 |
| T12 | 0.632 |
| hERG | 0.002 |
| Ames | 0.911 |
| ROA | 0.866 |
| SkinSen | 0.894 |
| Carcinogencity | 0.939 |
| EI | 0.991 |
| Respiratory | 0.966 |
| NR-Aromatase | 0.114 |
| Antiviral | No |
| Prediction | 0.937673 |